medigraphic.com
ISSN 1405-8871 (Print)

2017, Number 1

<< Back Next >>

Aten Fam 2017; 24 (1)

Prevalence of Candida albicans and its Relation with pH Vaginal Changes

Sánchez-Hernández JA, González-Belén L, Rojas-Valderrama K, Muñoz-Zurita G

Language: Spanish
References: 36
Page: 18-22
PDF size: 657.16 Kb.


ABSTRACT

Objective: to identify the prevalence of Candida albicans and its relation with vaginal pH changes. Methods: 412 shots of cervix-vaginal samples were analyzed in order to detect cervical cancer and incidence of C. albicans and vaginal pH. The samples were obtained by the technique of papanicolaou. Results: 412 patients were studied, 104 (25%) presented C. albicans infection, which is associated with greater frequency to vaginal pH of 5. Conclusion: C. albicans is the main agent of vulvovaginitis fungal, it is associated with an incidence to vaginal pH of 5, however, and being an important factor it is not considered the unique manifestation of the disease.


REFERENCES

  1. Villanueva RJ, Arenas R. Candidiasis mucocutánea. Una revisión. Rev Mex de Micología. 2007;25:91-104.

  2. James TY, Kauff F, Schoch CL, Matheny PB, Hofstetter V, Cox CJ, et al. Reconstructing the early evolution of Fungi using a six-gene phylogeny. Nature. 2006;443(7113):818-22.

  3. Gorka Barrenetxea Z. Vulvovaginitis candidiásica. Rev Iberoam Micol. 2002;19:22-4.

  4. Akinbiyi AA, Watson R, Feyi-Waboso P. Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom. Outcome of prospective study. Arch Gynecol Obstet. 2008;278(5):463-6.

  5. AndrioliI JL, Andrade OGS, BarretoIIl CS, Sousa Z, Haun OMC, Cazorla IM, et al. Frequência de leveduras em fluido vaginal de mulher com e sem suspeita clínica de candidíase vulvovaginal. Rev. Bras. Ginecol. Obstet. 2009;31(6):300-4.

  6. Álvares CA, Estivalet STI, Lopes CME. Candidíase vulvovaginal: fatores predisponentes do hospedeiro e virulência das leveduras. J Bras Patol Med Lab. 2007;43(5):319-27.

  7. Arcaya NM, Mesa LM, Pineda MR, Beltrán LH, Milagros CB. Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela. Rev Iberoam Micol. 2006;23(2):97-100.

  8. Gonçalves SCR, MeloII KE, Pereira LeãoI MV, RuisIII R, Cardoso Jorge AO. Presença de Candida nas mucosas vaginal e bucal e sua relação com IgA salivar. Rev. Bras. Ginecol. Obstet. 2008;30(6):300-5.

  9. Rivera SR, Flores PR, Arriaga AM.Identificación de especies de Candida causantes de vaginitis en la población mexicana. Enferm Infecc Microbiol Clin. 2006;24(10):634-6.

  10. Boatto HF, Moraes MS, Machado AP, Girão MJ, Batista C, Fischman O. Correlação entre os resultados laboratoriais e os sinais e sintomas clínicos das pacientes com candidíase vulvovaginal e relevância dos parceiros sexuais na manutenção da infecção em São Paulo, Brasil. Rev. Bras. Ginecol. Obstet. 2007;29(2):80-4.

  11. Buscemi L, Arechavala A, Negroni R. Estudio de las vulvovaginitis agudas en pacientes adultas, sexualmente activas, con especial referencia a la candidiasis, en pacientes del hospital de infecciosas Francisco J. Muñiz. Rev Iberoam Micol. 2004;21(1):177-81.

  12. Weissenbacher TM, Witkin SS, Gingelmaier A, Scholz C, Friese K, Mylonas I. Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid. Eur J Obstet Gynecol Reprod Biol. 2009;144(1):59-63.

  13. Ono F, Yasumoto S. Genital candidiasis. Nihon Rinsho. 2009;67(1):157-61.

  14. Ji F, Zhang N, Di W, LiaoQP, WangW, ZhaoXM, et al. Investigation of the situation of vaginal microflora in healthy women population. Zhonghua Fu Chan Ke Za Zhi. 2009;44(1):9-12.

  15. Sugita T, Kurosaka S, Yajitate M, Sato H, Nishikawa A. Extracellular proteinase and phospholipase activity of three genotypic strains of a human pathogenic yeast, Candida albicans. Microbiol Immunol. 2002;46(12):881-3.

  16. Naglik JR, Fostira F, Ruprai J, Staab JF, Challacombe SJ, Sundstrom P. Candida albicans hwp1 gene expression and host antibody responses in colonization and disease. J Med Microbiol. 2006;55(10):1323-7.

  17. Kang SW, Kauls LS, Gaspari AA. Toll-like receptors: Applications to dermatologic disease. Journal of the American Academy of Dermatology [Internet]. 2006;54(6):951-83. Disponible en: http://www.sciencedirect.com/science/article/pii/S0190962205014453

  18. Netea MG, Gow NA, Munro CA, Bates S, Collins C, Ferwerda G, et. al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin Invest. 2006;116(6):1642-50.

  19. Guevara J, Béjar VCA, Valencia E. Variedades de Candida en Mujeres con Flujo Vaginal Anormal. Anales de la Facultad de Medicina. 2000;61(1):51-4.

  20. Lilly EA, Leigh JE, Joseph SH, Fidel PL Jr. Candida-induced oral epithelial cell responses. Mycopathologia. 2006;162(1):25-32.

  21. Llovera SV, Perurena LMR. Identificación de levaduras de exudados vaginales: características clínicas asociadas a la candidiasis. Rev Cubana Med Trop. 2004;56(1):21-5.

  22. González PAA, Ortiz ZC, Dávila MR, Valencia GCM. Infecciones cervicovaginales más frecuentes; prevalencia y factores de riesgo. Rev Cubana Obstet Ginecol. 2007;33(2):1-12.

  23. Tarry W, Fisher M, Shen S, Mawhinney M. Candida albicans: the estrogen target for vaginal colonization. J Surg Res. 2005;129(2):278-82.

  24. Fischer G, Bradford J. Vulvovaginal candidiasis in postmenopausal women: the role of hormone replacement therapy. J Low Genit Tract Dis. 2011;15(4):263-7.

  25. Rylander E, Berglund A, Krassny C, Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect. 2004;80(1):54-7.

  26. Fernández CA, Fernández CM. El pH vaginal y su importancia clínica. Ginecol Obstet Clin. 2004;5:75-80.

  27. Giraldo PC, Gonçalves AK, Junior JE. Secretory immunoglobulin A: a protective factor in the genital mucosa. Braz J Infect Dis. 2006;10(4):232-4.

  28. Dalben DKF, Suemi SC, Valéria PE, Lopes CME, Estivalet STI. Susceptibilidad de levaduras vaginales a los antifúngicos más utilizados en Maringá, Paraná, Brasil. Acta Bioquím Clín Latinoam. 2008;42(4):561-6.

  29. Ouyang W, Chen S, Liu Z, Wu Y, Li J. Local Th1/Th2 cytokine expression in experimental murine vaginal candidiasis. J Huazhong Univ Sci Technolog Med Sci. 2008;28(3):352-5.

  30. Osset J, García E, Bartolomé RM, Andreu A. Papel de Lactobacillus como factor protector de la candidiasis vaginal. Medicina Clínica. 2001;117(8):285-8.

  31. Thulkar J, Kriplani A, Agarwal N. Utility of pH test & Whiff test in syndromic approach of abnormal vaginal discharge. Indian J Med Res. 2010;131:445-8.

  32. Biasoli MS, Tosello ME, Bottai H, Cuesta C, Magaró HM. Efecto de la temperatura y el pH en la adherencia de Candida albicans in vitro. Rev Iberoam Micol. 1999;16:46-9.

  33. Vera DM, Slobodanka VD, Nataša Zo, Milan KD, Lazar TR. Hydrogen peroxide producing lactobacilli in women with vaginal infections. Eur J Obstet Gynecol Reprod Biol. 2006;129(1):69-76.

  34. Brown D, Breton S. V-ATPase dependent luminal acidification in the kidney collecting duct and the epididymis/vas deferens. J Exp Biol. 2000;203(1):137-45.

  35. Melis GB, Ibba MT, Steri B, Kotsonis P, Matta V, Paoletti AM. Role of pH as a regulator of vaginal physiological environment. Minerva Ginecol. 2000;52(4):111-21.

  36. Ombrella AM, Racca L, Ramos L. Protease and phospholipase activities of Candida albicans isolated from vaginal secretions with different pH values. Iberoam Micol. 2008;25(1):12-6.




2020     |     www.medigraphic.com